By Walt Hickey Liking Numlock? Forward today’s email to a friend you think may enjoy it and might subscribe. Heart It’s been a 19-year process, but finally the transcatheter aortic valve replacement (TAVR) procedure has firmly entered the mainstream, with future conversations about TAVR being more about surgery as the alternative, rather than TAVR being an alternative to surgery. Sure, it’s less profitable for hospitals — TAVR valves cost $30,000 compared to the $6,000 for surgical valves, yet reimbursement from Medicare and Medicaid is similar — but the results are better and TAVR is way less invasive. The width of the devices is down to about 5 millimeters compared to the 8 millimeters it began at, and fears that implantation could cause strokes have been put at ease with a recently presented study finding 1 percent of TAVR recipients suffered a stroke, compared to 3 percent of those who underwent surgery. The market,
Numlock News: March 20, 2019
Numlock News: March 20, 2019
Numlock News: March 20, 2019
By Walt Hickey Liking Numlock? Forward today’s email to a friend you think may enjoy it and might subscribe. Heart It’s been a 19-year process, but finally the transcatheter aortic valve replacement (TAVR) procedure has firmly entered the mainstream, with future conversations about TAVR being more about surgery as the alternative, rather than TAVR being an alternative to surgery. Sure, it’s less profitable for hospitals — TAVR valves cost $30,000 compared to the $6,000 for surgical valves, yet reimbursement from Medicare and Medicaid is similar — but the results are better and TAVR is way less invasive. The width of the devices is down to about 5 millimeters compared to the 8 millimeters it began at, and fears that implantation could cause strokes have been put at ease with a recently presented study finding 1 percent of TAVR recipients suffered a stroke, compared to 3 percent of those who underwent surgery. The market,